Multidisciplinary Approach to AE Management With Lorlatinib

Opinion
Video

Medical experts discuss approaches to dose modifications and treatment interruptions for adverse events with ALK inhibitors, highlighting multidisciplinary management strategies and integrating best practices into electronic medical records.

Video content above is prompted by the following:

  • How do you handle dose modifications or treatment interruptions due to adverse events?
  • Can you share any experiences where such modifications significantly impacted patient outcomes?
  • What multidisciplinary approaches have you found most effective in managing the diverse range of adverse events associated with ALK inhibitors?
  • Do you have any tips for how to include AE management strategies in EMR or another central system so everyone has access to best practices for handling?
Recent Videos
Smiling woman in front of a blue video call background with logos that say "All in Against Cancer" and "Ochsner Health" above her
Man standing in front of Oncology Nursing News-branded backdrop
Image of a woman in an office, taken as a screenshot from the video interview
woman in front of a dark blue background for Oschner Health
Related Content